Scynexis (SCYX) Reports Q2 Loss of $0.78/Share

Go back to Scynexis (SCYX) Reports Q2 Loss of $0.78/Share

SCYNEXIS, Inc. Reports Second Quarter 2015 Financial Results

August 19, 2015 6:00 PM EDT

RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq: SCYX) today reported financial results for the second quarter of 2015.

"In reflecting on the first quarter and subsequent period of my tenure as CEO at SCYNEXIS, I've been impressed by the dedication and performance of my team and the progress we have achieved. This has been a transformative period for us as we completed a follow-on public offering that provides a solid financial position, accomplished the divestiture of the services business which allows us... More

SCYNEXIS, Inc. Reports Second Quarter 2015 Financial Results

August 19, 2015 6:00 PM EDT

RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Drug discovery and development company SCYNEXIS, Inc. (Nasdaq: SCYX) today reported financial results for the second quarter of 2015.

"In reflecting on the first quarter and subsequent period of my tenure as CEO at SCYNEXIS, I've been impressed by the dedication and performance of my team and the progress we have achieved. This has been a transformative period for us as we completed a follow-on public offering that provides a solid financial position, accomplished the divestiture of the services business which allows us... More